Literature DB >> 32164893

Emerging Techniques for Risk Stratification in Nonischemic Dilated Cardiomyopathy: JACC Review Topic of the Week.

Benjamin A Marrow1, Stuart A Cook2, Sanjay K Prasad3, Gerry P McCann4.   

Abstract

Dilated cardiomyopathy (DCM) is a common condition, which carries significant mortality from sudden cardiac death and pump failure. Left ventricular ejection fraction has conventionally been used as a risk marker for sudden cardiac death, but has performed poorly in trials. There have been significant advances in the areas of cardiac magnetic resonance imaging and genetics, which are able to provide useful rick prediction in DCM. Biomarkers and cardiopulmonary exercise testing are well validated in the prediction of risk in heart failure; however, they have been tested less specifically in the DCM setting. This review will discuss these methods with a view toward multiparametric risk assessment in DCM with the hope of creating parametric risk models to predict sudden cardiac death and pump failure in the DCM population.
Copyright © 2020 American College of Cardiology Foundation. All rights reserved.

Entities:  

Keywords:  biomarkers; cardiac magnetic resonance; cardiopulmonary exercise testing; dilated cardiomyopathy; genetics; nonischemic cardiomyopathy

Mesh:

Year:  2020        PMID: 32164893     DOI: 10.1016/j.jacc.2019.12.058

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  5 in total

1.  RBM20 mutation and ventricular arrhythmias in a young patient with dilated cardiomyopathy: a case report.

Authors:  Ioannis Liatakis; Efstathia Prappa; Aggeliki Gouziouta; Malena P Pantou; Polyxeni Gourzi; Konstantinos Vlachos; Panagiotis Mililis; Ourania Kariki; Dimitrios Degiannis; Michael Efremidis; Konstantinos P Letsas
Journal:  Am J Cardiovasc Dis       Date:  2021-06-15

2.  A machine-learning-based method to predict adverse events in patients with dilated cardiomyopathy and severely reduced ejection fractions.

Authors:  Shenglei Shu; Ziming Hong; Qinmu Peng; Xiaoyue Zhou; Tianjng Zhang; Jing Wang; Chuansheng Zheng
Journal:  Br J Radiol       Date:  2021-08-31       Impact factor: 3.039

Review 3.  Well-Known and Novel Serum Biomarkers for Risk Stratification of Patients with Non-ischemic Dilated Cardiomyopathy.

Authors:  Larisa Anghel; Radu Sascău; Ioana Mădălina Zota; Cristian Stătescu
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

4.  Immunoadsorption treatment for dilated cardiomyopathy: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Ru-Tao Bian; Zhen-Tao Wang; Wei-Yu Li
Journal:  Medicine (Baltimore)       Date:  2021-07-02       Impact factor: 1.817

Review 5.  Beyond Ejection Fraction: Novel Clinical Approaches Towards Sudden Cardiac Death Risk Stratification in Patients with Dilated Cardiomyopathy.

Authors:  Issa Pour-Ghaz; Mark Heckle; Ikechukwu Ifedili; Sharif Kayali; Christopher Nance; Rajesh Kabra; Sunil K Jha; John L Jefferies; Yehoshua C Levine
Journal:  Curr Cardiol Rev       Date:  2022
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.